Trade Puma Biotechnology, Inc. - PBYI CFD
What is Puma Biotechnology (PBYI)?
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of various cancers. Founded in 2010, the company specializes in targeted oncology drugs, particularly in the areas of breast cancer and other solid tumors. Puma Biotechnology's research and development efforts include advancing compounds through clinical trials to address unmet medical needs. The company collaborates with medical institutions and regulatory agencies to bring new therapies to market. Headquartered in Los Angeles, California, Puma Biotechnology operates within the biotechnology sector, emphasizing precision medicine and personalized treatment approaches.
Puma Biotechnology Stock Price Today: Live Overview
The price today is shaped by market movement, with Puma Biotechnology priced at $6.9156. Intraday fluctuations range from $6.4944 to $6.9544, with a daily change of +1.4849%.
FAQ: Puma Biotechnology (PBYI)
What is the current price of PBYI stock?
The current price stands at $6.9156.
Does PBYI pay dividends?
Dividends are not paid by the company.
Does PBYI have a formal corporate presence or regional headquarters in the UAE?
Puma Biotechnology does not have an official regional office or subsidiary in the UAE and operates through distributors only.
What is PBYI best known for?
Puma Biotechnology is most famous for its development of oncology drugs.
What assets are typically shown together with PBYI?
Commonly shown alongside PBYI: NY Times, Workday, JFrog Ltd.
Latest shares articles



